Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

Learn more about GLP-1 pills and how they may be more convenient and cost-effective than the injections.

New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...

The GLP-1 injection is seen as a shortcut to the desired weight. What many now consider a lifestyle drug is actually a prescription medication, with risks, side effects, and clear limits. In a FITBOOK ...

Discontinuing obesity medicines often means the weight comes back and people lose the cardiovascular and metabolic benefits ...

New research has found that 50% of patients regain the weight they lost if they stop taking Wegovy and Zepbound ...

By Nancy Lapid Jan 22 (Reuters) - Many patients using highly effective GLP-1 drugs like Wegovy may not regain lost weight ...

After a period of diversification, Novo Nordisk is returning to its roots by focusing on the 2 billion people with diabetes, ...

Sun Pharmaceutical Industries announced that it has received approval from the Drugs Controller General of India (DCGI) to manufacture and market a generic version of semaglutide injection.

While they slash appetite, they do not reduce the body’s need for essential nutrients ...

At a high level these drugs mimic glucagon-like peptide-1, or GLP-1, a hormone our bodies naturally produce in the gut. When ...

When someone loses weight quickly with GLP-1 medication, body changes are expected. But shifts in the face and skin such as ...